Examples of using Sivextro in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Sivextro contains sodium.
How is Sivextro used?
Other information about Sivextro.
Why is Sivextro approved?
If you stop taking Sivextro.
What Sivextro looks like and contents of the pack.
Other medicines and Sivextro.
Sivextro can only be obtained with a prescription.
What are the risks associated with Sivextro?
Sivextro vials are intended for single use only.
Your doctor will have decided if Sivextro is suitable to treat your infection.
Sivextro 200 mg powder for concentrate tedizolid phosphate.
The following adverse reactions have been identified in twocomparative pivotal Phase 3 studies with Sivextro Table 1.
Sivextro must be administered by intravenous infusion over a 60-minute period.
Tell your doctor straight away if you suffer from any of the following while taking Sivextro.
Sivextro is an antibiotic that contains the active substance tedizolid phosphate.
Tell your doctor or nurse immediately if you are concerned that you mayhave been given too much Sivextro.
Sivextro 200 mg powder for concentrate for solution for infusion tedizolid phosphate.
In both studies patients received 6 days of treatment with Sivextro which was compared with a 10-day treatment of linezolid.
Sivextro is an oval, yellow film-coated tablet imprinted with‘TZD' on one side and‘200' on the other side.
These events have been observed with another member of the oxazolidinone class when administered over a duration exceeding that recommended for Sivextro.
In the event of overdose, Sivextro should be discontinued and general supportive treatment given.
Certain side effects have been observed with another member of the oxazolidinone classwhen administered over a duration exceeding that recommended for Sivextro.
If you stop taking Sivextro without the advice of your doctor, your symptoms may get worse.
Sivextro is a white to off-white powder for concentrate for solution for infusion in a glass vial.
Approximately 22.4% of patients treated with Sivextro in Phase 3 clinical studies(n= 662) experienced at least one treatment-emergent adverse reaction.
Sivextro is indicated for the treatment of acute bacterial skin and skin structure infections(ABSSSI) in adults see sections 4.4 and 5.1.
The contents of Sivextro should be reconstituted with 4 mL of water for injections, and be swirled gently until the powder has dissolved entirely.
Sivextro may have a minor influence on the ability to drive and use machines as it may cause dizziness, fatigue or, uncommonly, somnolence see section 4.8.
Sivextro was compared with linezolid(another oxazolidinone) in two main studies involving a total of 1,333 patients with acute bacterial infections of the skin and of skin structures, such as cellulitis, skin abscesses and wound infections.